PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Honours AarhusKarlshamn with Product Differentiation Excellence Award for DELIAIR™ NH - The 2010 Frost & Sullivan European Product Differentiation Excellence Award in Confectionary Ingredients is presented to AarhusKarlshamn
Frost & Sullivan Honours AarhusKarlshamn with Product Differentiation Excellence Award for DELIAIR™ NH

 

NewswireToday - /newswire/ - London, United Kingdom, 2011/01/24 - The 2010 Frost & Sullivan European Product Differentiation Excellence Award in Confectionary Ingredients is presented to AarhusKarlshamn.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

"Consumer demands have compelled confectionery manufacturers to produce food which is not only tasty, but also healthy," states Frost & Sullivan Research Analyst Dr. Kaushik Shankar.

"AarhusKarlshamn's DELIAIR™ NH, focuses on avoiding the use of hydrogenated and trans-fats as constituents. DELIAIR™ NH also offers a range of added advantages including longer shelf life due to the unique technology incorporated in the manufacture of the ingredient and reduction in the total fat content of the confectionery product in which it is used."

Confectionery fillings are generally very dense, lipid rich ingredients which can satisfy the consumer's sensory requirements. AarhusKarlshamn has worked with the basic structure of lipid molecules to devise a technology for making fillings with vegetable fats without compromising on shelf life or taste.

"By sidestepping the requirement of water to increase the volume of filling fats, the minimum shelf life of such ingredients has been extended beyond six months," explains Dr. Shankar. "Again, migration of water in these ingredients is an issue which affects the final stability of products. Both these issues have successfully been addressed by AarhusKarlshamn with its unique patented technology."

DELIAIR™ NH is capable of being customised at multiple levels. It can be combined with multiple flavours and ingredients to give the exact taste and mouth feel profile that the customer requires.

Features like consistency and moisture level can also be customised, allowing DELIAIR™ NH to cater to even niche segments of the market. For example, soft, aerated fillings that are able to retain their structure have been developed to meet the specific request of customers.

"Competing products have to contend with inherent deficiencies in product formulation that prevent this degree of customization," notes Dr. Shankar. "The wide range of applications and customisation levels offered by AarhusKarlshamn for DELIAIR™ NH is unmatched."

Successful products are able to bring about the perfect balance between health and indulgence, hence delighting the customer. DELIAIR™ NH succeeds on both counts.

"DELIAIR™ NH is able to supply 200% additional volume with just 33% of the fat that would normally be used," comments Dr. Shankar. "This contributes to a significant reduction in the total calories that would normally be used for making a confection of the same volume."

At the same time, DELIAIR™ NH is capable of being used with multiple flavour options. DELIAIR™ NH has the highest whipping capacity among all filling fats available in the market. In addition, it also has high bloom stability and melting characteristics. It differentiates itself in the market with superlative whipping and customisation abilities.

AarhusKarlshamn counts as its client all leading Multi National Companies. It is a firm believer in 'Platform Innovation'; the involvement of the company in the entire product development exercise of the customer has ensured that new products consistently match client expectations and are introduced within record time in the market.

Every client has a 'customer approach team' assigned to them which includes sales, marketing and technical personnel from AarhusKarlshamn. There is a single point of contact within the company for client query redressal.

"Regular sensory analyses of products developed using DELIAIR™ NH is carried out by the customer with the company's support for maintaining quality and advancing product development," concludes Dr. Shankar. "The success of these initiatives is visible in the sales targets of the company, which has witnessed spectacular success in achieving the target set for the fourth year of launch within the first year itself."

The Product Differentiation Excellence Award is presented to the company that has excelled in the following criteria: unique features/functionality, quality/complexity, customisation, matched to target markets needs and brand perception of the uniqueness of the product.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About AarhusKarlshamn (AAK)

AarhusKarlshamn (AAK) is the result of a merger in 2005 between the Danish company Aarhus United (established 1871) and the Swedish company Karlshamn (established 1918). Today AAK refines speciality vegetable oils for multiple uses. AAK is the world's leading producer of speciality fats including substitutes for dairy fat and cocoa butter, as transfree solutions for fillings for chocolate and confectionery products, as well as for the cosmetics industry. AAK has production facilities in Denmark, Mexico, the Netherlands, United Kingdom, Sweden, Uruguay and the USA. The company is listed on NASDAQ OMX Stockholm, in the Mid Cap segment, Consumer Commodities sector.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Honours AarhusKarlshamn with Product Differentiation Excellence Award for DELIAIR™ NH

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Emily Bailey 
+44 (0)20 7915 7869 emily.bailey[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)